Get the Stockscreener App
10.26
8.92%
0.84
Transcode Therapeutics Inc stock is traded at $10.26, with a volume of 10,798.
It is up +8.92% in the last 24 hours and up +8.69% over the past month.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
See More
Previous Close:
$9.42
Open:
$9.5
24h Volume:
10,798
Relative Volume:
0.22
Market Cap:
$8.55M
Revenue:
-
Net Income/Loss:
$-14.93M
P/E Ratio:
-0.0386
EPS:
-266.137
Net Cash Flow:
$-15.87M
1W Performance:
-4.91%
1M Performance:
+8.69%
6M Performance:
-95.46%
1Y Performance:
-96.01%
1-Day Range:
$9.50
$10.45
1-Week Range:
$9.4104
$10.74
52-Week Range:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Name
Transcode Therapeutics Inc
Sector
Industry
Phone
857-301-6857
Address
6 LIBERTY SQUARE, BOSTON
Compare RNAZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
10.26 | 8.75M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Stock (RNAZ) Latest News
Understanding TransCode Therapeutics Inc.’s price movementIndex Update & Safe Entry Zone Tips - Newser
Using data models to predict TransCode Therapeutics Inc. stock movementWeekly Trade Recap & Safe Capital Preservation Plans - Newser
What’s next for TransCode Therapeutics Inc. stock price2025 EndofYear Setup & High Accuracy Trade Alerts - Newser
Analyzing TransCode Therapeutics Inc. with multi timeframe chartsJuly 2025 Price Swings & Verified Momentum Stock Watchlist - Newser
Earnings visualization tools for TransCode Therapeutics Inc.Earnings Recap Report & Low Drawdown Investment Ideas - Newser
TransCode Therapeutics Inc. stock momentum explainedJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
TransCode Therapeutics Inc. stock outlook for YEARQuarterly Profit Report & Risk Managed Investment Entry Signals - Newser
Visual trend scoring systems applied to TransCode Therapeutics Inc.Weekly Profit Analysis & Technical Buy Zone Confirmations - Newser
Does TransCode Therapeutics Inc. show high probability of reboundQuarterly Earnings Report & Safe Entry Point Alerts - Newser
Sentiment analysis tools applied to TransCode Therapeutics Inc.2025 Investor Takeaways & AI Driven Price Forecasts - Newser
Best data tools to analyze TransCode Therapeutics Inc. stock2025 Major Catalysts & Weekly High Return Opportunities - Newser
Why TransCode Therapeutics Inc. stock attracts strong analyst attention2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser
Can momentum traders help lift TransCode Therapeutics Inc.Quarterly Earnings Summary & High Yield Equity Trading Tips - Newser
Building trade automation scripts for TransCode Therapeutics Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Using Ichimoku Cloud for TransCode Therapeutics Inc. technicalsJuly 2025 Final Week & Free Community Consensus Stock Picks - Newser
Can TransCode Therapeutics Inc. expand its profit marginsPortfolio Performance Report & Verified Short-Term Trading Plans - thegnnews.com
TransCode Therapeutics Inc. May Be Forming Higher Low — Chartwatchers AlertVolume Spike & Free High Accuracy Swing Entry Alerts - 선데이타임즈
MACD Signals Flash Warning for TransCode Therapeutics Inc. StockJuly 2025 Price Swings & Reliable Intraday Trade Alerts - sundaytimes.kr
Will Breakout in TransCode Therapeutics Inc. Sustain Through Next WeekWeekly Gains Summary & Consistent Profit Alerts - sundaytimes.kr
Order Flow Trends Show Accumulation in TransCode Therapeutics Inc.July 2025 Reactions & Reliable Entry Point Alerts - beatles.ru
TransCode Therapeutics Inc. Shows Support at Fibonacci LevelWeekly Profit Recap & Community Verified Trade Signals - 선데이타임즈
Is TransCode Therapeutics Inc. exposed to political riskJuly 2025 Momentum & Risk Controlled Swing Alerts - thegnnews.com
Top Risks to Consider Before Buying TransCode Therapeutics Inc. StockMomentum Detection with Entry Optimization - Newser
What makes TransCode Therapeutics Inc. stock price move sharplyReal-Time Equity Price Action Analysis - Newser
When is the best time to exit TransCode Therapeutics Inc.Chart Driven Opportunity Scanner with Alerts - Newser
Is TransCode Therapeutics Inc. the Top Chart Pick This WeekTrade Scanner With Buy Zone Alerts Flagged - metal.it
Why ATCO.PRH stock attracts strong analyst attentionMarket Sentiment Tracker with Smart Alerts - Newser
Is TransCode Therapeutics Inc. a growth stock or a value stockCapitalize on momentum-driven opportunities - Jammu Links News
Does TransCode Therapeutics Inc. stock perform well during market downturnsExceptional profit margins - Jammu Links News
Is it the right time to buy TransCode Therapeutics Inc. stockTremendous return on equity - Jammu Links News
When is TransCode Therapeutics Inc. stock expected to show significant growthMaximize your portfolio’s earning potential - Jammu Links News
Why is TransCode Therapeutics Inc. stock attracting strong analyst attentionCapitalize on fast-growing investment opportunities - Jammu Links News
How does TransCode Therapeutics Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - Jammu Links News
What institutional investors are buying TransCode Therapeutics Inc. stockBuild a winning investment portfolio - Jammu Links News
How volatile is TransCode Therapeutics Inc. stock compared to the marketUnprecedented growth rates - Jammu Links News
Relative strength of TransCode Therapeutics Inc. in sector analysisAI Screener Based Stock Summary Report - Newser
Will TransCode Therapeutics Inc. stock benefit from interest rate changesFree Low Risk Swing Trade Opportunity List - Newser
Using RSI to spot recovery in TransCode Therapeutics Inc.Triple Digit Gain Opportunity Watchlist - Newser
Analyzing recovery setups for TransCode Therapeutics Inc. investorsFree Trade Setups With AI Powered Filters - Newser
Signal strength of TransCode Therapeutics Inc. stock in tech scannersWatchlist Generator With Real-Time Entry - Newser
Candlestick signals on TransCode Therapeutics Inc. stock todayOptimized Watchlist With Daily Adjustments Launched - metal.it
Will breakout in TransCode Therapeutics Inc. lead to full recoveryFree Trend Following Strategy With Stop Loss - Newser
TransCode Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayEntry Optimization Tool with Screener Logic - Newser
Using flow based indicators on TransCode Therapeutics Inc.Technical Trend Forecast for Investors - Newser
Should you hold or exit TransCode Therapeutics Inc. nowMinimal Risk Growth Investment Opportunity Analysis - Newser
Real time alert setup for TransCode Therapeutics Inc. performanceVolume Spike Detection for Early Breakouts - Newser
Transcode Therapeutics Inc Stock (RNAZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):